证券之星消息，12月18日南向资金减持14.57万股微创医疗（00853.HK）。近5个交易日中，获南向资金 减持的有5天，累计净减持2490.95万股。近20个交易日中，获南向资金减持的有9天，累计净减持 1652.42万股。截至目前，南向资金持有微创医疗（00853.HK）8.8亿股，占公司已发行普通股的 45.97%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公 司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器 械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大 动脉及外周血管介入业务分部包括"L-REBOA"主动脉阻断球囊等产品。神经介入业务分部包括脑动脉 粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人 业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。 ...

证券之星消息，12月17日南向资金减持462.28万股微创医疗（00853.HK）。近5个交易日中，获南向资 金减持的有5天，累计净减持2664.61万股。近20个交易日中，获南向资金减持的有8天，累计净减持 1616.69万股。截至目前，南向资金持有微创医疗（00853.HK）8.8亿股，占公司已发行普通股的 45.98%。 微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公 司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器 械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大 动脉及外周血管介入业务分部包括"L-REBOA"主动脉阻断球囊等产品。神经介入业务分部包括脑动脉 粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人 业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Core Viewpoint - Southbound funds have reduced their holdings in MicroPort Scientific Corporation (00853.HK) by 2.3773 million shares on December 15, with a total net reduction of 6.2569 million shares over the past five trading days [1] Group 1: Southbound Fund Activity - In the last 20 trading days, southbound funds have increased their holdings on 13 days, resulting in a total net increase of 6.1746 million shares [1] - As of now, southbound funds hold 900.1 million shares of MicroPort, accounting for 47.08% of the company's total issued ordinary shares [1] Group 2: Company Overview - MicroPort Scientific Corporation primarily engages in the sales, production, research, and development of medical devices [1] - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [1]

Core Insights - Southbound funds increased their holdings in MicroPort Medical (00853.HK) by 310,000 shares on December 9, with a total net increase of 5.3182 million shares over the last five trading days [1] - Over the past 20 trading days, there were 15 days of net increases, totaling 14.1728 million shares [1] - As of now, southbound funds hold 907 million shares of MicroPort Medical, accounting for 47.42% of the company's total issued ordinary shares [1] Company Overview - MicroPort Medical Science Co., Ltd. is primarily engaged in the sales, production, research, and development (R&D) of medical devices [1] - The company operates through eight divisions, including: - Cardiovascular Interventional Business: Products include implantable devices and access devices [1] - Orthopedic Medical Devices: Focuses on joint reconstruction and spinal instruments [1] - Cardiac Rhythm Management (CRM): Involves pacemakers and defibrillators [1] - Aortic and Peripheral Vascular Interventional Business: Includes products like the "L-REBOA" aortic occlusion balloon [1] - Neurointerventional Business: Products for treating cerebral artery atherosclerosis and coils [1] - Structural Heart Disease Business: Involves transcatheter aortic valve implantation [1] - Surgical Robotics Business: Engaged in the manufacturing and R&D of surgical robotic devices [1] - Surgical Medical Devices: Focuses on the manufacturing and R&D of surgical medical instruments [1]

Core Insights - Southbound funds increased their holdings in MicroPort Medical (00853.HK) by 2.36 million shares on December 3, 2025, marking a total net increase of 10.81 million shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have increased their holdings on 12 occasions, resulting in a cumulative net increase of 8.71 million shares [1] - As of now, southbound funds hold 904 million shares of MicroPort Medical, accounting for 47.27% of the company's total issued ordinary shares [1] Summary by Category Shareholding Changes - On December 3, 2025, total shares held reached 904 million, with a change of 2.36 million shares, representing a 0.26% increase [2] - On December 2, 2025, total shares held were 902 million, with a change of 2.54 million shares, representing a 0.28% increase [2] - On December 1, 2025, total shares held were 276.68 million, with a change of 361,100 shares, representing a 0.04% increase [2] - On November 28, 2025, total shares held were 266.8 million, with a change of 1.55 million shares, representing a 0.17% increase [2] - On November 27, 2025, total shares held were 898 million, with a change of 4 million shares, representing a 0.45% increase [2] Company Overview - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices [2] - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, large artery and peripheral vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [2]

Core Viewpoint - Southbound funds have significantly increased their holdings in MicroPort Scientific Corporation (00853.HK), indicating strong investor interest and confidence in the company's performance [1]. Group 1: Southbound Fund Holdings - On December 1, southbound funds increased their holdings by 361,100 shares [2]. - Over the past five trading days, there were four days of net increases, totaling 6,722,700 shares [1]. - In the last 20 trading days, there were 11 days of net increases, amounting to 9,681,000 shares [1]. - As of now, southbound funds hold 899 million shares of MicroPort, representing 47.01% of the company's total issued ordinary shares [1]. Group 2: Trading Data Summary - On December 1, total shares held were 266.8 million, with a change of 361,100 shares, reflecting a 0.04% increase [2]. - On November 28, total shares held were 266.8 million, with a change of 1,550,400 shares, reflecting a 0.17% increase [2]. - On November 27, total shares held were 898 million, with a change of 4,000,100 shares, reflecting a 0.45% increase [2]. - On November 26, total shares held were 894 million, with a change of 1,115,800 shares, reflecting a 0.13% increase [2]. - On November 25, total shares held were 892 million, with a change of -304,700 shares, reflecting a -0.03% decrease [2]. Group 3: Company Overview - MicroPort Scientific Corporation is primarily engaged in the sales, production, research, and development of medical devices [2]. - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [2].

Group 1 - The core point of the article is that southbound funds have increased their holdings in MicroPort Medical (00853.HK) by 211,600 shares on November 20, 2025, with a total net increase of 3.815 million shares over the last five trading days and 16.5963 million shares over the last 20 trading days [1][2] - As of now, southbound funds hold 896 million shares of MicroPort Medical, accounting for 46.84% of the company's total issued ordinary shares [1][2] Group 2 - The trading data shows fluctuations in shareholding, with a total holding of 896 million shares on November 20, 2025, reflecting a change of 0.02% [2] - The company operates in the medical device sector, focusing on sales, production, research, and development across eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, and surgical robotics [2]

Core Insights - Southbound funds increased their holdings in MicroPort Medical (00853.HK) by 270,000 shares on November 13, 2025, while experiencing a net reduction of 2,834,000 shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have increased their holdings on 13 occasions, resulting in a net increase of 21,939,700 shares [1] - As of now, southbound funds hold 892 million shares of MicroPort Medical, accounting for 46.64% of the company's total issued ordinary shares [1] Trading Data Summary - On November 13, 2025, total shares held were 892 million, with a change of 270,000 shares, reflecting a 0.03% increase [2] - On November 12, 2025, total shares held remained at 892 million, with a decrease of 1,038,100 shares, indicating a -0.12% change [2] - On November 11, 2025, total shares held were 276,680, with a reduction of 692,300 shares, showing a -0.08% change [2] - On November 10, 2025, total shares held were 894 million, with an increase of 171,400 shares, reflecting a 0.02% change [2] - On November 7, 2025, total shares held were 894,700, with a decrease of 1,545,000 shares, indicating a -0.17% change [2] Company Overview - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices [2] - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, vascular intervention, neurointervention, structural heart disease, surgical robotics, and surgical medical devices [2]

Core Viewpoint - Southbound funds have significantly increased their holdings in MicroPort Medical (00853.HK), indicating strong investor interest and confidence in the company [1]. Group 1: Southbound Fund Activity - On October 31, southbound funds increased their holdings by 1.4855 million shares, marking a 0.17% change [2]. - Over the past five trading days, there have been four days of net increases, totaling 4.09 million shares [1]. - In the last 20 trading days, there were 15 days of net increases, amounting to 51.2419 million shares [1]. - As of now, southbound funds hold 886 million shares of MicroPort Medical, which represents 46.31% of the company's total issued ordinary shares [1]. Group 2: Company Overview - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices [2]. - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, and surgical robotics [2]. - Key products include implantable devices, spinal instruments, and surgical robots, among others [2].